Study Information

Alliance Study ID: NCCTG-N0048

NCT Study ID (ClinicalTrials.gov): NCT00016952

Disease or Cancer Type: Colorectal / Colon / Rectal Cancer

Alliance Study Chair: Henry C. Pitot, MD

Status: COMPLETED


Study Description

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more tumor cells.

PURPOSE: Phase II trial to compare the effectiveness of either irinotecan or fluorouracil plus leucovorin in treating patients who have metastatic colorectal cancer that has been previously treated with oxaliplatin with or without irinotecan.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials